Skip to main content
Clinical Trials/NCT02791581
NCT02791581
Active, not recruiting
Not Applicable

Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)

Wake Forest University Health Sciences66 sites in 1 country403 target enrollmentJuly 21, 2017
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Wake Forest University Health Sciences
Enrollment
403
Locations
66
Primary Endpoint
Change in FACT-Fatigue Results
Status
Active, not recruiting
Last Updated
6 months ago

Overview

Brief Summary

This study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not have cancer.

Detailed Description

840 women aged ≥18 years old scheduled to receive chemotherapy for Stage I-III breast cancer and a comparison population of 160 women without cancer (1,000 total). Equal numbers of women will be recruited aged \< 52 vs. \> 52. At baseline, innovative MRI measures of CV function (LV and aorta); measurements of submaximal (6-minute walk) and, on 45% of the cohort, maximal (peak VO2) exercise capacity; questionnaire data to assess fatigue and behavioral and psychosocial risk factors; and biomarkers will be collected. Measurements will be repeated at 3±1, 12±2 and 24±2 months. This study will assess the relevance of pre-existing factors such as age, black/white race, hypertension, smoking (yes/no), diabetes, coronary artery disease, menopause status, CV medications, and physical activity on the study outcomes. Also, this study will assess dynamic change in modifiable CV risk factors (including BMI, blood pressure, serum lipids, serum glucose, physical activity, psychosocial factors, lifestyle behaviors), and the cancer treatment including chemotherapy, radiation therapy, immunotherapy, and surgery.

Registry
clinicaltrials.gov
Start Date
July 21, 2017
End Date
July 31, 2034
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in FACT-Fatigue Results

Time Frame: Baseline, 3 months, 12 months and 24 months

Participants rate the degree to which each item applies in the past 7 days using a 5-point scale. Scores range from 0-52, with higher scores indicating greater fatigue.

Change in 6 Minute Walk Results

Time Frame: Baseline, 3 months, 12 months and 24 months

The purpose of this test is to find out how far the participant can walk in 6 minutes.

FACT-Fatigue

Time Frame: Baseline

Participants rate the degree to which each item applies in the past 7 days prior to Baseline using a 5-point scale. Scores range from 0-52, with higher scores indicating greater fatigue.

Change in MRI Exam Results

Time Frame: Baseline, 3 months and 24 months

The exam will measure left ventricular volumes, ejection fraction, myocardial strain/strain rate, mass, mapping, aortic pulse wave velocity and aortic wall thickness. The exam will take 10 - 15 minutes to complete.

Secondary Outcomes

  • Cohen's 4-item Perceived Stress Scale (PSS)(Baseline, 3 months, 12 months, and 24 months)
  • Cook-Medley Hostility Scale(Baseline)
  • Changes in FACT-Fatigue Results(Baseline, 3 months, 12 months, and 24 months)
  • 6 Minute Walk Results(Baseline, 3 months, 12 months and 24 months)
  • RAND MOS 36-item Short Form Health Survey (SF-36)(Baseline, 3 months, 12 months and 24 months)
  • Center for Epidemiological Studies Depression Scale (CESD-10)(Baseline, 3 months, 12 months and 24 months)
  • Godin Leisure-Time Exercise Questionnaire (LTEQ)(Baseline, 3 months, 12 months and 24 months)
  • PACE Adult Sedentary Behaviors Survey(Baseline, 3 months, 12 months and 24 months)
  • PROMIS Short Form 8A Measure of Sleep Disturbance(Baseline, 3 months, 12 months and 24 months)
  • PROMIS Applied Cognitive Abilities Short Form 8A and Applied Cognition General Concerns Short Form 8A(Baseline, 3 months, 12 months and 24 months)
  • Walking Efficacy for Duration Scale(Baseline, 3 months, 12 months and 24 months)
  • Chair Stands - Measures Leg Strength(Baseline, 3 months, 12 months and 24 months)
  • Standing Balance Test(Baseline, 3 months, 12 months and 24 months)
  • Gait Speed Test(Baseline, 3 months, 12 months and 24 months)
  • Grip Strength(Baseline, 3 months, 12 months and 24 months)
  • Range of Motion(Baseline, 3 months, 12 months and 24 months)
  • KCCQ-12 Questionnaire(Baseline, 24 months)

Study Sites (66)

Loading locations...

Similar Trials